New study identifies biological mechanism driving therapy resistance in advanced prostate cancerNovember 3, 2026
General Abiraterone triplet therapy improves long-term survival in metastatic prostate cancerBy Healthcare Propulsion StaffOctober 25, 20260 Adding abiraterone to standard treatment provides a lasting survival benefit for men whose prostate cancer has already spread at diagnosis,…
General Dual-targeted therapy shows promise against metastatic triple-negative breast cancerBy Healthcare Propulsion StaffOctober 23, 20260 A new preclinical study suggests that attacking triple-negative breast cancer (TNBC) in two ways at once can kill cancer cells,…
